Clinical Trials Directory

Trials / Completed

CompletedNCT04664712

Efficacy of Focused Shock Waves Combined With Adjuvant Therapy With Tendon Supplement

Efficacy of Focused Shock Waves Combined With Adjuvant Therapy With Tendon Supplement in the Treatment of Plantar Fasciitis: a Prospective Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Physical treatment with focused shock waves is effective in the treatment of tendonitis. Food supplements could facilitate the healing of tendinopathies when combined with shock wave therapy.

Detailed description

A single-blind, randomized prospective study (level of evidence IB) was designed. Patients with plantar fasciitis were recruited and randomized to group A and group B. Group A was treated with focused shock waves alone and group B with a combination of focused shock waves and tendon supplement. Pain remission (primary endpoint) and functional recovery (secondary endpoint) are monitored in both groups at three time points (Months 0, 3, and 6).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTendisulfur ProDietary supplement based on Methylsulfonylmethane (2.5 g), hydrolyzed collagen (1 g), L-arginine (1 g), L-lysine (500 mg), Vitamin C (500 mg), Bromelain (200 mg), Chondroitin sulfate (150 mg), Glucosamine (150 mg) \[17, 18\], dry extracts of turmeric (100 mg), Boswellia (100 mg) and Myrrh (50 mg)
DEVICEFocused shock waveWe delivered 2000 shots per session using a low/medium energy level (range between 0.01 and 0.175 milliJoule/mm2) depending on the patient's tolerance during treatment with a frequency of 4 Hz.

Timeline

Start date
2019-09-11
Primary completion
2020-05-01
Completion
2020-11-20
First posted
2020-12-11
Last updated
2020-12-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04664712. Inclusion in this directory is not an endorsement.